Illovo Sugar Africa Pty Ltd:企業の戦略的SWOT分析

◆英語タイトル:Illovo Sugar Africa Pty Ltd - Strategic SWOT Analysis Review
◆商品コード:DATA904C13178
◆発行会社(調査会社):GlobalData
◆発行日:2019年1月
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:南アフリカ
◆産業分野:材料
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Illovo Sugar Africa Pty Ltd – Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.

Highlights

Illovo Sugar Africa Pty Ltd (Illovo Sugar), a subsidiary of Associated British Foods plc, is a supplier of sugar and other derivatives. The company’s product portfolio comprises brown and refined sugar, industrial sugar, pre-pack sugar, bulk raw sugar, specialty sugars and syrup. Illovo Sugar also offers various sugar derivatives including furfural, agriguard, furfuryl alcohol, diacetyl and 2.3-pentanedione, biomass sugar, lactulose and ethyl alcohol. The company operates agricultural and manufacturing operations in Tanzania, Zambia, Mozambique, Malawi, Swaziland and South Africa. Apart from Africa, it markets its products across the US and the European Union countries. It is also involved in electricity co-generation. Illovo Sugar is headquartered in Umhlanga Rocks, Durban, South Africa.

Illovo Sugar Africa Pty Ltd Key Recent Developments

May 24,2018: Zambia Sugar Plc’s Interim Results – 28 Feb 2018

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
Section 1 – About the Company 5
Illovo Sugar Africa Pty Ltd – Key Facts 5
Illovo Sugar Africa Pty Ltd – Key Employees 6
Illovo Sugar Africa Pty Ltd – Major Products and Services 7
Illovo Sugar Africa Pty Ltd – History 8
Illovo Sugar Africa Pty Ltd – Company Statement 9
Illovo Sugar Africa Pty Ltd – Locations And Subsidiaries 10
Head Office 10
Other Locations & Subsidiaries 10
Section 2 – Company Analysis 12
Company Overview 12
Illovo Sugar Africa Pty Ltd – Business Description 13
Illovo Sugar Africa Pty Ltd – SWOT Analysis 14
SWOT Analysis – Overview 14
Illovo Sugar Africa Pty Ltd – Strengths 14
Illovo Sugar Africa Pty Ltd – Weaknesses 15
Illovo Sugar Africa Pty Ltd – Opportunities 16
Illovo Sugar Africa Pty Ltd – Threats 17
Illovo Sugar Africa Pty Ltd – Key Competitors 18
Section 3 – Company’s Recent Developments 19
May 24, 2018: Zambia Sugar Plc’s Interim Results – 28 Feb 2018 19
Section 4 – Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Illovo Sugar Africa Pty Ltd, Key Facts 5
Illovo Sugar Africa Pty Ltd, Key Employees 6
Illovo Sugar Africa Pty Ltd, Major Products and Services 7
Illovo Sugar Africa Pty Ltd, History 8
Illovo Sugar Africa Pty Ltd, Other Locations 10
Illovo Sugar Africa Pty Ltd, Subsidiaries 11
Illovo Sugar Africa Pty Ltd, Key Competitors 18

★海外企業調査レポート[Illovo Sugar Africa Pty Ltd:企業の戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • GeNeuro SA (GNRO):企業の財務・戦略的SWOT分析
    Summary GeNeuro SA (GeNeuro) operates as a clinical stage pharmaceutical company that manufactures therapeutic product pipeline for disorders of the nervous system. The company provides treatments against inflammatory and degenerative disorders associated with endogenous retroviruses. GeNeuro develo …
  • Kang Stem Biotech Co Ltd (217730):製薬・医療:M&Aディール及び事業提携情報
    Summary Kang Stem Biotech Co Ltd (Kang Stem Biotech) is a biopharmaceutical company that develops stem cell therapeutic products for the treatment of incurable diseases using umbilical cord blood-derived stem cells. The company’s stem cell therapy products include Furestem-AD for treating subacute a …
  • Hitachi, Ltd.:企業のM&A・事業提携・投資動向
    Hitachi, Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Hitachi, Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • Tullow Oil plc:戦略・SWOT・企業財務分析
    Tullow Oil plc - Strategy, SWOT and Corporate Finance Report Summary Tullow Oil plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • EVN AG:企業の発電所・SWOT分析2018
    EVN AG - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executives) …
  • Esperite NV (ESP):企業の財務・戦略的SWOT分析
    Esperite NV (ESP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Rubis SCA (RUI):企業の財務・戦略的SWOT分析
    Rubis SCA (RUI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Martin Midstream Partners L.P.:企業のM&A・事業提携・投資動向
    Martin Midstream Partners L.P. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Martin Midstream Partners L.P. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers a …
  • Ability Pharmaceuticals SL:製薬・医療:M&Aディール及び事業提携情報
    Summary Ability Pharmaceuticals SL (Ability Pharma), formerly AB Therapeutics SL is a biopharmaceutical company that discovers and develops human therapeutics for the treatment of cancer and other indications. The company’s lead pipeline drug candidate includes ABTL0812, a new drug class of small mo …
  • Twilio Inc (TWLO):企業の財務・戦略的SWOT分析
    Twilio Inc (TWLO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Uber Technologies Inc:企業の戦略・SWOT・財務情報
    Uber Technologies Inc - Strategy, SWOT and Corporate Finance Report Summary Uber Technologies Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Ohishi Sangyo Co., Ltd.:企業の戦略・SWOT・財務情報
    Ohishi Sangyo Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Ohishi Sangyo Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • United Natural Foods Inc:企業の戦略・SWOT・財務情報
    United Natural Foods Inc - Strategy, SWOT and Corporate Finance Report Summary United Natural Foods Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • InnaVirVax SA-製薬・医療分野:企業M&A・提携分析
    Summary InnaVirVax SA (InnaVirVax) is a biopharmaceutical company which discovers and develops products for the treatment of HIV/AIDS infection pathologically and novel cancer therapies. The company's pipeline product portfolio comprise DIAG-3S, an AIDS prognostic test; VAC-3S, an HIV AIDs therapeut …
  • Amer Sports Corporation:企業の戦略・SWOT・財務情報
    Amer Sports Corporation - Strategy, SWOT and Corporate Finance Report Summary Amer Sports Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Stock Spirits Group PLC:企業の戦略・SWOT・財務分析
    Stock Spirits Group PLC - Strategy, SWOT and Corporate Finance Report Summary Stock Spirits Group PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Ajinomoto Co., Inc.:企業の戦略・SWOT・財務情報
    Ajinomoto Co., Inc. - Strategy, SWOT and Corporate Finance Report Summary Ajinomoto Co., Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Apollo Hospitals Enterprise Ltd (APOLLOHOSP):製薬・医療:M&Aディール及び事業提携情報
    Summary Apollo Hospitals Enterprise Ltd (Apollo Hospitals) is a healthcare service provider. It offers healthcare services, clinical and diagnostic services, medical business process outsourcing, third party administration services and health insurance. The company also provides services to support …
  • TIS Inc (3626):企業の財務・戦略的SWOT分析
    TIS Inc (3626) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Hybrigenics SA (ALHYG):製薬・医療:M&Aディール及び事業提携情報
    Summary Hybrigenics SA (Hybrigenics) is a biopharmaceutical company that develops new targets and therapies against proliferative and non-cancerous diseases. Its lead product candidate Inecalcitol, is a vitamin D receptor agonist being assessed for various cancer indications including prostate cance …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆